Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.


Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.

We are delighted to announce that Toby Simpson has joined HOFFMANN EITLE as a partner.


Toby, who is based in our London office, joins us from another top-tier firm, where he was a partner for eight years.  Toby’s patent practice lies in the fields of pharmaceuticals and chemistry.  He has extensive experience of opposition and appeal proceedings before the EPO, and regularly represents clients in relation to such matters.  In particular, Toby has successfully defended numerous patents directed to blockbuster drugs, as well as patents directed to medical devices and well-known cosmetic products.


Commenting on this development, Morten Garberg, a member of the firm’s management committee, said: “We are truly excited that Toby has joined HOFFMANN EITLE.  Toby brings with him a wealth of experience across a range of technical disciplines, as well as an exceptional reputation for handling opposition and appeals.  HOFFMANN EITLE has one of the largest and best-known chemistry practices in Europe, and Toby’s addition will further enhance the firm’s expertise and global reputation in this area.”